ArticleFrontiers in endocrinology2025
Developing a novel diagnostic model for identifying high-risk plaques in new onset unstable angina pectoris using coronary CT angiography.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vessel-specific perivascular fat attenuation index derived from AI-CCTA and its association with impaired coronary flow reserve in patients with INOCA.International journal of cardiology. Heart & vasculature · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Limited evidence supports the use of electronic health records for developing prediction models to identify high-risk plaques in patients with unstable angina pectoris (UAP). This study aimed to develop and validate a practical high-risk plaque prediction model in patients with new onset UAP. Methods: We prospectively enrolled consecutive patients presenting with new-onset UAP who underwent both coronary angiography and coronary computed tomography angiography (CCTA) at our center from January 2021 to December 2021. Based on the CCTA findings, the patients were categorized into two distinct groups: a high-risk plaque group (n=57) and a low-risk plaque group (n=26). We utilized LASSO regression and the Boruta algorithm for feature selection and performed multivariate logistic regression analyses to identify variables associated with high-risk plaque. Internal validity of the predictive model was assessed using bootstrapping (500 replications). Results: We developed a nomogram to predict high-risk plaque likelihood using LASSO regression, the Boruta algorithm, and multivariate logistic regression analyses. This approach identified four clinical features as significant predictors: diabetes mellitus, current smoking, total cholesterol, and lipoprotein(a). The area-under-the-curve (AUC) values, calculated using the bootstrap method with 500 replicates, for evaluating high-risk plaque in both the development and validation cohorts, were 0.851, accompanied by a 95% Confidence Interval (CI) ranging from 0.768 to 0.935. The nomogram exhibited satisfactory calibration when assessed with the bootstrap method (500 replicates), indicating a strong correlation with high-risk plaque as determined by CCTA. Furthermore, decision curve analysis indicated the clinical utility of this nomogram in accurately predicting high-risk plaque. And a web-based dynamic nomogram was further built to facilitate the prediction procedure. Conclusions: Our prediction nomogram, developed using electronic health records, demonstrated robust capability in accurately identifying high-risk plaque among new onset patients with UAP. The implementation of this predictive tool holds great potential for tailoring individualized treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.